HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Post hoc mortality analysis on the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock.

AuthorsC Gillon Ward, Edward P Sloan
JournalThe Journal of trauma (J Trauma) Vol. 53 Issue 5 Pg. 1031; author reply 1031-2 (Nov 2002) ISSN: 0022-5282 [Print] United States
PMID12435966 (Publication Type: Letter, Comment)
Chemical References
  • Hemoglobins
  • diaspirin-cross-linked hemoglobin
  • Aspirin
Topics
  • Aspirin (analogs & derivatives, therapeutic use)
  • Hemoglobins (therapeutic use)
  • Humans
  • Shock, Hemorrhagic (drug therapy, mortality)
  • Shock, Traumatic (drug therapy, mortality)
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: